drug
filgrastim
Marketedupdated 3mo agoby Kashiv BioSciences LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagRecall3 co-mentions · 3 sources
- drugtbo-filgrastim2 co-mentions · 1 sources
- drugFILKRI2 co-mentions · 1 sources
- companyTeva Pharmaceuticals USA Inc2 co-mentions · 1 sources
- tagApproval2 co-mentions · 1 sources
- company$AMGNAMGEN INC2 co-mentions · 2 sources
- drugfilgrastim biosimilar1 co-mentions · 1 sources
- companyAccord Biopharma Inc1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying filgrastim
- phase2Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- phase2Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
- phase2Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- phase2Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
- phase2Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
- phase2Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
- phase1Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing
- phase1Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that